Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

EBV Infection Alters NK Cell Phenotype Distinctly From hCMV

MO. Ustiuzhanina, JD. Vavilova, MA. Salnikova, AA. Chertkova, NA. Alekseeva, AA. Boyko, AI. Palamarchuk, MA. Streltsova, DM. Chudakov, EI. Kovalenko

. 2025 ; 97 (10) : e70620. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25021410

Grantová podpora
The study was supported by the Russian Science Foundation grant No. 24-75-10136.

Natural killer (NK) cells are vital in the antiviral response regulated by inhibitory and activating receptors, including NKG2 and KIR families, which bind HLA-I. While the adaptive features of NK cells in response to human cytomegalovirus (hCMV) have been well described, their behavior during Epstein-Barr virus (EBV) infection and the influence of KIR-HLA combinations in healthy carriers of these viruses remains unclear. We performed high-resolution HLA genotyping, phenotypic profiling of NK cell subsets, and serological testing for hCMV and EBV-specific IgG in 85 healthy adult donors. hCMV-seropositive individuals exhibited significant expansions of NKG2C+ and HLA-DR+ NK cell subsets, with the proportion of NKG2C+ cells strongly correlating with hCMV-IgG titers. In contrast, EBV infection was associated with increased frequencies of terminally differentiated CD56dim, NKG2A-, CD57+ NK cells and elevated expression of inhibitory KIRs, but not NKG2C or HLA-DR. EBV-IgG titers correlated with CD57 and KIR2DS4 levels. Among KIR2DS4-expressing donors, carriage of at least one HLA-C2 allele was associated with elevated EBV-IgGs. The precise analysis of KIR2DL2/DL3, KIR2DS4, and KIR2DL1 revealed dependencies on EBV-IgG titers, with no associations with hCMV. These findings highlight the differential impacts of hCMV and EBV on NK cells and underscore the relevance of HLA-KIR landscapes in shaping antiviral immunity.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25021410
003      
CZ-PrNML
005      
20251023075626.0
007      
ta
008      
251014s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/jmv.70620 $2 doi
035    __
$a (PubMed)41002189
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Ustiuzhanina, Maria O $u Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia $u Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia $u Center for Molecular and Cellular Biology, Moscow, Russia $1 https://orcid.org/0000000333786508
245    10
$a EBV Infection Alters NK Cell Phenotype Distinctly From hCMV / $c MO. Ustiuzhanina, JD. Vavilova, MA. Salnikova, AA. Chertkova, NA. Alekseeva, AA. Boyko, AI. Palamarchuk, MA. Streltsova, DM. Chudakov, EI. Kovalenko
520    9_
$a Natural killer (NK) cells are vital in the antiviral response regulated by inhibitory and activating receptors, including NKG2 and KIR families, which bind HLA-I. While the adaptive features of NK cells in response to human cytomegalovirus (hCMV) have been well described, their behavior during Epstein-Barr virus (EBV) infection and the influence of KIR-HLA combinations in healthy carriers of these viruses remains unclear. We performed high-resolution HLA genotyping, phenotypic profiling of NK cell subsets, and serological testing for hCMV and EBV-specific IgG in 85 healthy adult donors. hCMV-seropositive individuals exhibited significant expansions of NKG2C+ and HLA-DR+ NK cell subsets, with the proportion of NKG2C+ cells strongly correlating with hCMV-IgG titers. In contrast, EBV infection was associated with increased frequencies of terminally differentiated CD56dim, NKG2A-, CD57+ NK cells and elevated expression of inhibitory KIRs, but not NKG2C or HLA-DR. EBV-IgG titers correlated with CD57 and KIR2DS4 levels. Among KIR2DS4-expressing donors, carriage of at least one HLA-C2 allele was associated with elevated EBV-IgGs. The precise analysis of KIR2DL2/DL3, KIR2DS4, and KIR2DL1 revealed dependencies on EBV-IgG titers, with no associations with hCMV. These findings highlight the differential impacts of hCMV and EBV on NK cells and underscore the relevance of HLA-KIR landscapes in shaping antiviral immunity.
650    _2
$a lidé $7 D006801
650    12
$a buňky NK $x imunologie $x virologie $7 D007694
650    12
$a infekce virem Epsteina-Barrové $x imunologie $x virologie $7 D020031
650    _2
$a dospělí $7 D000328
650    12
$a Cytomegalovirus $x imunologie $7 D003587
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    12
$a virus Epsteinův-Barrové $x imunologie $7 D004854
650    _2
$a lidé středního věku $7 D008875
650    12
$a cytomegalovirové infekce $x imunologie $x virologie $7 D003586
650    _2
$a receptory KIR $x genetika $x imunologie $7 D054340
650    _2
$a protilátky virové $x krev $7 D000914
650    _2
$a imunoglobulin G $x krev $7 D007074
650    _2
$a fenotyp $7 D010641
650    _2
$a mladý dospělý $7 D055815
650    _2
$a genotyp $7 D005838
650    _2
$a lektinové receptory NK-buněk - podrodina C $7 D055654
650    _2
$a HLA antigeny $x genetika $7 D006680
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vavilova, Julia D $u Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia $1 https://orcid.org/000000029075218X
700    1_
$a Salnikova, Maria A $u Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia $u Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia $u Department of Immunology, Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia
700    1_
$a Chertkova, Aglaya A $u Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia $u Department of Immunology, Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia
700    1_
$a Alekseeva, Nadezhda A $u Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia
700    1_
$a Boyko, Anna A $u Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia
700    1_
$a Palamarchuk, Anastasia I $u Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia
700    1_
$a Streltsova, Maria A $u Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia
700    1_
$a Chudakov, Dmitriy M $u Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia $u Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia $u Center for Molecular and Cellular Biology, Moscow, Russia $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic $u Abu Dhabi Stem Cell Center, Al Muntazah, United Arab Emirates
700    1_
$a Kovalenko, Elena I $u Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia
773    0_
$w MED00002794 $t Journal of medical virology $x 1096-9071 $g Roč. 97, č. 10 (2025), s. e70620
856    41
$u https://pubmed.ncbi.nlm.nih.gov/41002189 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20251014 $b ABA008
991    __
$a 20251023075632 $b ABA008
999    __
$a ok $b bmc $g 2416685 $s 1259573
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 97 $c 10 $d e70620 $e - $i 1096-9071 $m Journal of medical virology $n J Med Virol $x MED00002794
GRA    __
$p The study was supported by the Russian Science Foundation grant No. 24-75-10136.
LZP    __
$a Pubmed-20251014

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...